Adherence to standards of care and mortality in the management of Staphylococcus aureus bacteraemia in Peru: A prospective cohort study
- PMID: 32505877
- DOI: 10.1016/j.ijid.2020.06.002
Adherence to standards of care and mortality in the management of Staphylococcus aureus bacteraemia in Peru: A prospective cohort study
Abstract
Background: Despite high mortality rates, physicians can alter the course of the Staphylococcus aureus bacteraemia (SAB) by following recommended standards of care. We aim to assess the adherence of these guidelines and their impact on mortality.
Methods: Substudy from a prospective cohort of hospitalized patients with SAB from three hospitals from Peru. Hazard ratios were calculated using Cox proportional regression to evaluate the association between 30-day mortality and the performance of standards of care: removal of central venous catheters (CVC), follow-up blood cultures, echocardiography, correct duration, and appropriate definitive antibiotic therapy.
Results: 150 cases of SAB were evaluated; 61.33% were MRSA. 30-day attributable mortality was 22.39%. CVC removal was done in 42.86% of patients. Follow-up blood cultures and echocardiograms were performed in 8% and 29.33% of cases, respectively. 81.33% of cases had appropriate empirical treatment, however, only 22.41% of MSSA cases were given appropriate definitive treatment, compared to 93.47% of MRSA. The adjusted regression for all-cause mortality found a substantial decrease in hazards when removing CVC (aHR 0.28, 95% CI: 0.10 - 0.74) and instituting appropriate definitive treatment (aHR 0.27, 95% CI: 0.08 - 0.86), while adjusting for standards of care, qPitt bacteraemia score, comorbidities, and methicillin susceptibility; similar results were found in the attributable mortality model (aHR 0.24, 95% CI: 0.08 - 0.70 and aHR 0.21, 95% CI: 0.06 - 0.71, respectively).
Conclusions: Deficient adherence to standards of care was observed, especially definitive treatment for MSSA. CVC removal and the use of appropriate definitive antibiotic therapy reduced the hazard mortality of SAB.
Keywords: MRSA; MSSA; Mortality; Standards of care; Staphylococcus aureus.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.Clin Microbiol Infect. 2020 May;26(5):626-631. doi: 10.1016/j.cmi.2019.07.019. Epub 2019 Jul 26. Clin Microbiol Infect. 2020. PMID: 31357013
-
A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study.Lancet Infect Dis. 2014 Oct;14(10):967-75. doi: 10.1016/S1473-3099(14)70876-X. Epub 2014 Aug 31. Lancet Infect Dis. 2014. PMID: 25185461
-
Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.Ann Clin Microbiol Antimicrob. 2016 Feb 9;15:7. doi: 10.1186/s12941-016-0122-8. Ann Clin Microbiol Antimicrob. 2016. PMID: 26860463 Free PMC article.
-
Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.J Antimicrob Chemother. 2010 Dec;65(12):2658-65. doi: 10.1093/jac/dkq373. Epub 2010 Oct 14. J Antimicrob Chemother. 2010. PMID: 20947620 Review.
-
MRSA bacteraemia.Int J Antimicrob Agents. 2007 Nov;30 Suppl 1:S66-70. doi: 10.1016/j.ijantimicag.2007.06.023. Epub 2007 Sep 17. Int J Antimicrob Agents. 2007. PMID: 17875386 Review.
Cited by
-
Meta-meta-analysis of the mortality risk associated with MRSA compared to MSSA bacteraemia.Infez Med. 2024 Jun 1;32(2):131-137. doi: 10.53854/liim-3202-2. eCollection 2024. Infez Med. 2024. PMID: 38827830 Free PMC article. Review.
-
Evolution of Antimicrobial Resistance Levels of ESKAPE Microorganisms in a Peruvian IV-Level Hospital.Infect Chemother. 2021 Sep;53(3):449-462. doi: 10.3947/ic.2021.0015. Epub 2021 Aug 17. Infect Chemother. 2021. PMID: 34508324 Free PMC article.
-
The Prognostic Role of Pitt Bacteremia Score in Patients With Nonbacteremic Klebsiella pneumoniae Infections.Can J Infect Dis Med Microbiol. 2025 Jul 15;2025:6780766. doi: 10.1155/cjid/6780766. eCollection 2025. Can J Infect Dis Med Microbiol. 2025. PMID: 40697809 Free PMC article.
-
Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Hospitalized Patients in Peru.Am J Trop Med Hyg. 2023 Sep 18;109(5):1118-1121. doi: 10.4269/ajtmh.23-0054. Print 2023 Nov 1. Am J Trop Med Hyg. 2023. PMID: 37722664 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical